Researchers tested the accuracy of real-time polymerase chain reaction for detecting CDAD after infection rates at the hospital increased following PCR usage for detection.
Researchers screened patients for C. diff using real-time PCR, a toxin enzyme-linked immunosorbent assay and a toxigenic culture.
C. diff was detected in 18 percent of the participants using real-time PCR detection. Of the patients with detected C. diff, 72 percent had asymptomatic C. diff colonization.
Researchers suggest PCR detection may be contributing to the rising rates of CDAD by reporting false positives, as asymptomatic C. diff colonization is overrepresented in actual CDAD rates. They also suggest further studies are needed to develop a standard in CDAD diagnostic testing and to guide PCR detection interpretation.
More Articles on C. diff:
Most Common Healthcare-Associated Infections: 25 Bacteria, Viruses Causing HAIs
Sepsis Patients With C. diff Infections Linked to Increased Mortality, LOS, Cost
Concord Hospital Uses UV Light Robot to Target C. Diff
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
